Clinical Trials Logo
  1. Home
  2. Ulcers
  3. NCT00688428

Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

Ulcers Clinical Trial

Official title:
A Phase I, Open-Label, Randomized, Single-Center, 2-Stage Group Sequential Design, 2-Way Crossover Bioequivalence Study Comparing a Fixed-Dose Combination Capsule of Esomeprazole 40mg and Low-Dose Acetylsalicylic Acid (ASA) 325mg With a Free Combination of Esomeprazole Capsule 40mg and Low-Dose ASA

Clinical Trial Summary

The purpose of this study is to test if fixed dose esomeprazole and ASA capsule is pharmaceutically equal to a free combination of esomeprazole capsule and ASA tablet

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00688428
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 1
Start date April 2008
Completion date April 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT01214811 - Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Phase 3
Terminated NCT00700154 - Insulin Infusion Diabetes Ulcer N/A
Completed NCT01138436 - A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers Phase 2
Completed NCT01548378 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia Phase 2
Completed NCT01942941 - Peripheral Vascular Disease and Nerve Stimulation N/A
Completed NCT00718978 - Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS) N/A
Completed NCT00951080 - SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds N/A
Suspended NCT00701974 - Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers Phase 2/Phase 3
Completed NCT01474109 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Terminated NCT01474122 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Completed NCT01439581 - Utility of Interface Pressure Mapping N/A
Completed NCT00597818 - Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury Phase 2
Completed NCT00189540 - Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers Phase 2
Recruiting NCT04275323 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) Phase 3
Completed NCT04274049 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) Phase 3